Vistin Pharma ASA (OSL:VISTN)

Vistin Pharma ASA Revenue

Vistin Pharma ASA had revenue of 108.39M NOK in the quarter ending September 30, 2026, a decrease of -0.41%. This brings the company's total for the last twelve months to 431.55M, down -5.20% year-over-year. In the year 2025, Vistin Pharma ASA had annual revenue of 452.29M with 5.31% growth. That makes Vistin Pharma ASA the 28,464th largest company in the world by revenue and 175th in Norway.

• Revenue (ttm): 431.55M
• Revenue Growth: -5.20%
• P/S Ratio: 1.89
• Revenue / Employee: 5.68M
• Employees: 77
• Market Cap: 835.90M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe 358.27M 79.2%
• Africa 49.64M 11.0%
• Asia 41.05M 9.1%
• North and South America 3.33M 0.7%

Fiscal year ended Dec 31, 2025 See the full Vistin Pharma ASA breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	452.29M	22.79M	5.31%
Dec 31, 2024	429.50M	-8.83M	-2.01%
Dec 31, 2023	438.33M	133.48M	43.78%
Dec 31, 2022	304.85M	26.23M	9.41%
Dec 31, 2021	278.62M	24.72M	9.74%
Dec 31, 2020	253.91M	25.78M	11.30%
Dec 31, 2019	228.13M	27.62M	13.77%
Dec 31, 2018	200.51M	14.66M	7.89%
Dec 31, 2017	185.86M	12.60M	7.27%
Dec 31, 2016	173.26M	-54.63M	-23.97%
Dec 31, 2015	227.89M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Oct 1, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error